To analyze how DTA-1 treatment influences the clonal diversity of CD4+Teffs and Tregs in tumor-bearing TCRmini mice, we first compared the frequencies of 35 most frequent clones in pLN, dLN, and tumor from untreated and DTA-1 treated mice. The gene discussed is CD4; the disease is neoplasm.